Back
Dianthus Therapeutics, Inc. Stock Price Chart
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
61
DNTH
Dianthus Therapeutics, Inc.
Last Price:
$44.26
Seasonality Move:
24.02%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNTH is experiencing slight selling pressure.
Dianthus Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.82 | Buy |
| 20-day SMA: | 41.15 | Buy |
| 50-day SMA: | 37.56 | Buy |
| 200-day SMA: | 25.66 | Buy |
| 8-day EMA: | 43.49 | Buy |
| 20-day EMA: | 41.41 | Buy |
| 50-day EMA: | 37.75 | Buy |
| 200-day EMA: | 29.12 | Buy |
Dianthus Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.25 | Buy |
| Relative Strength Index (14 RSI): | 65.7 | Buy |
| Chaikin Money Flow: | -48547 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.02 - 43.62) | Buy |
| Bollinger Bands (100): | (23.86 - 39.86) | Buy |
Dianthus Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dianthus Therapeutics, Inc. Stock
Is Dianthus Therapeutics, Inc. Stock a Buy?
-
Dianthus Therapeutics, Inc. share price is 44.26 while DNTH 8-day simple moving average is 43.82, which is a Buy signal.
-
The stock price of DNTH is 44.26 while Dianthus Therapeutics, Inc. 20-day SMA is 41.15, which makes it a Buy.
-
Dianthus Therapeutics, Inc. 50-day simple moving average is 37.56 while DNTH share price is 44.26, making it a Buy technically.
-
DNTH stock price is 44.26 and Dianthus Therapeutics, Inc. 200-day simple moving average is 25.66, creating a Buy signal.
DNTH Technical Analysis vs Fundamental Analysis
Buy
61
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Is Dianthus Therapeutics, Inc. a Buy or a Sell?
-
Dianthus Therapeutics, Inc. stock is rated a BuyThe current Dianthus Therapeutics, Inc. [DNTH] share price is $44.26. The Score for DNTH is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Dianthus Therapeutics, Inc. Stock Info
Market Cap:
1.9B
Price in USD:
44.26
Share Volume:
431K
Dianthus Therapeutics, Inc. 52-Week Range
52-Week High:
45.46
52-Week Low:
13.37
Buy
61
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Dianthus Therapeutics, Inc. Share Price Forecast
-
What is the Dianthus Therapeutics, Inc. stock price today?The Dianthus Therapeutics, Inc. stock price is 44.26 USD today.
-
Will DNTH stock go up or go down?Dianthus Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Dianthus Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dianthus Therapeutics, Inc. is not overvalued.
Is Dianthus Therapeutics, Inc. Stock a Buy?
-
Dianthus Therapeutics, Inc. share price is 44.26 while DNTH 8-day exponential moving average is 43.49, which is a Buy signal.
-
The stock price of DNTH is 44.26 while Dianthus Therapeutics, Inc. 20-day EMA is 41.41, which makes it a Buy.
-
Dianthus Therapeutics, Inc. 50-day exponential moving average is 37.75 while DNTH share price is 44.26, making it a Buy technically.
-
DNTH stock price is 44.26 and Dianthus Therapeutics, Inc. 200-day simple moving average is 29.12, creating a Buy signal.
Fundamental Analysis of Dianthus Therapeutics, Inc.
Is Dianthus Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.47 per share, and a decrease next year of $0.13 per share.
Technical Analysis of Dianthus Therapeutics, Inc.
Should I short Dianthus Therapeutics, Inc. stock?
-
DNTH Moving Average Covergence Divergence (MACD) indicator is 2.25, suggesting Dianthus Therapeutics, Inc. is a Buy
-
Dianthus Therapeutics, Inc. Relative Strength Index (RSI) is 65.7, which suggest Dianthus Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Dianthus Therapeutics, Inc. is (36.02 - 43.62), which suggest Dianthus Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Dianthus Therapeutics, Inc. is (23.86 - 39.86), which suggest Dianthus Therapeutics, Inc. is a Buy
* Dianthus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.